AR113011A1 - Vesículas extracelulares bacterianas - Google Patents
Vesículas extracelulares bacterianasInfo
- Publication number
- AR113011A1 AR113011A1 ARP180102564A ARP180102564A AR113011A1 AR 113011 A1 AR113011 A1 AR 113011A1 AR P180102564 A ARP180102564 A AR P180102564A AR P180102564 A ARP180102564 A AR P180102564A AR 113011 A1 AR113011 A1 AR 113011A1
- Authority
- AR
- Argentina
- Prior art keywords
- bacterium
- vesicules
- bacterial extracellular
- subject
- pharmaceutical composition
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Reivindicación 1: Una composición farmacéutica que comprende vesículas extracelulares (VE) bacterianas aisladas. Reivindicación 76: Un método para tratar una enfermedad en un sujeto que comprende administrar al sujeto una composición farmacéutica de acuerdo con una cualquiera de las reivindicaciones 1 - 15. Reivindicación 147: Una bacteria modificada generada de acuerdo con el método de cualquiera de las reivindicaciones 127 - 146. Reivindicación 148: Un método para cultivar una bacteria para una producción de VE mejorada, comprendiendo el método hacer crecer la bacteria en condiciones de crecimiento inductoras de estrés. Reivindicación 161: Un biorreactor que comprende una bacteria modificada de acuerdo con la reivindicación 147.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762556015P | 2017-09-08 | 2017-09-08 | |
US201862669151P | 2018-05-09 | 2018-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR113011A1 true AR113011A1 (es) | 2020-01-15 |
Family
ID=63832482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP180102564A AR113011A1 (es) | 2017-09-08 | 2018-09-10 | Vesículas extracelulares bacterianas |
Country Status (14)
Country | Link |
---|---|
US (2) | US11524037B2 (es) |
EP (1) | EP3678693A1 (es) |
JP (1) | JP7369690B2 (es) |
KR (1) | KR20200053531A (es) |
CN (1) | CN111148531A (es) |
AR (1) | AR113011A1 (es) |
AU (1) | AU2018330322A1 (es) |
BR (1) | BR112020004264A2 (es) |
CA (1) | CA3075268A1 (es) |
CO (1) | CO2020004233A2 (es) |
MA (1) | MA50086A (es) |
MX (1) | MX2020002659A (es) |
TW (1) | TWI814739B (es) |
WO (1) | WO2019051380A1 (es) |
Families Citing this family (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11542468B2 (en) * | 2016-06-14 | 2023-01-03 | Healthbiome | Agathobaculum sp. strain having prophylactic or therapeutic effects on degenerative brain diseases and use thereof |
ES2755815T3 (es) | 2016-09-13 | 2020-04-23 | Allergan Inc | Composiciones de toxina de Clostridium no proteicas estabilizadas |
US11590231B2 (en) | 2017-07-27 | 2023-02-28 | Locus Solutions Ipco, Llc | Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances |
MA50086A (fr) | 2017-09-08 | 2020-07-15 | Evelo Biosciences Inc | Vésicules extracellulaires (ev) bactériennes |
CN112074283A (zh) * | 2018-02-06 | 2020-12-11 | 伊夫罗生物科学公司 | 使用韦荣氏球菌属细菌治疗癌症和免疫病症的组合物和方法 |
KR102122898B1 (ko) * | 2018-02-26 | 2020-06-15 | 주식회사 엠디헬스케어 | 블라우티아 속 세균 유래 나노소포 및 이의 용도 |
WO2019178494A1 (en) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and inflammation using tyzzerella nexilis |
WO2019178487A2 (en) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae |
WO2019178490A1 (en) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and inflammation using klebsiella oxytoca |
CA3093709C (en) | 2018-03-16 | 2024-03-26 | Zoetis Services Llc | Peptide vaccines against interleukin-31 |
US20210205379A1 (en) * | 2018-05-30 | 2021-07-08 | University Of Florida Research Foundation, Incorporated | Mechanistic bacterial efector to prevent apoptosis of human beta cells |
CN108949699B (zh) * | 2018-08-03 | 2020-09-04 | 江南大学 | 一种分泌美洛昔康单克隆抗体的杂交瘤细胞株及其应用 |
US11541083B2 (en) | 2018-09-27 | 2023-01-03 | Research Development Foundation | Methods and probiotic compositions for the treatment of bone disorders |
CN109207425A (zh) * | 2018-09-29 | 2019-01-15 | 中国医科大学附属口腔医院 | 牙龈卟啉单胞菌诱导巨噬细胞外泌体rna表达研究方法 |
JP7240031B2 (ja) * | 2018-12-10 | 2023-03-15 | エムディー ヘルスケア インコーポレイテッド | ワイセラ属細菌由来のナノ小胞およびその用途 |
US20220047648A1 (en) * | 2019-01-09 | 2022-02-17 | Md Healthcare Inc. | Nanovesicles derived from bacteria of genus rhodococcus, and use thereof |
CN109762762A (zh) * | 2019-01-11 | 2019-05-17 | 江苏大学 | 一种脂肽的高产菌株及其制备方法和用途 |
KR102285335B1 (ko) * | 2019-02-14 | 2021-08-04 | 주식회사 엠디헬스케어 | 로치아 속 세균 유래 나노소포 및 이의 용도 |
BR112021016605A2 (pt) * | 2019-02-22 | 2022-01-18 | Evelo Biosciences Inc | Preparações de membrana bacteriana |
CN110195028B (zh) * | 2019-03-08 | 2022-03-01 | 大连理工大学 | 一种堆肥低温复合发酵菌剂的制备方法及应用 |
WO2020214961A1 (en) * | 2019-04-17 | 2020-10-22 | Codiak Biosciences, Inc. | Methods of treating tuberculosis |
CN111991427A (zh) * | 2019-05-07 | 2020-11-27 | 瑞微(深圳)生物科技有限公司 | 肠道细菌在制备用于促进TCR γδ+T细胞增殖的药物中的应用 |
CN110317744B (zh) * | 2019-05-08 | 2021-11-05 | 安徽农业大学 | 一种生产蓝紫色素的马赛菌及其生产蓝紫色素的方法 |
WO2020252149A1 (en) * | 2019-06-11 | 2020-12-17 | Evelo Biosciences, Inc. | Processed microbial extracellular vesicles |
BR112021025788A2 (pt) | 2019-06-20 | 2022-03-03 | Locus Ip Co Llc | Cocultivo de uma mixobactéria e acinetobacter para produção potencializada de emulsan |
CA3147629A1 (en) * | 2019-07-19 | 2021-01-28 | Finch Therapeutics Holdings Llc. | Methods and products for treatment of gastrointestinal disorders |
MX2022001607A (es) * | 2019-08-05 | 2022-03-11 | Evelo Biosciences Inc | Composiciones y metodos para tratar la psoriasis y la dermatitis atopica usando prevotella histicola. |
CN110577910B (zh) * | 2019-09-17 | 2022-02-01 | 南京农业大学 | 一种侧孢短芽孢杆菌、抗菌脂肽及其在农业与食品上的应用 |
CN114401727A (zh) * | 2019-09-18 | 2022-04-26 | 研究发展基金会 | 用于治疗代谢性疾病和病症的方法和益生菌组合物 |
CN110628862A (zh) * | 2019-09-24 | 2019-12-31 | 哈尔滨工业大学 | 一种废水梯级能源回收的自聚集颗粒污泥构建方法 |
CN110982729A (zh) * | 2019-10-23 | 2020-04-10 | 江苏省中国科学院植物研究所 | 一种降解木材加工副产物杨树皮纤维素的复合菌剂 |
CN110804621A (zh) * | 2019-10-31 | 2020-02-18 | 郑州大学 | 一种内源性高表达miRNA的大肠杆菌胞外囊泡的制备方法 |
US20230081756A1 (en) * | 2019-12-31 | 2023-03-16 | Xbiome Inc. | Compositions comprising bacterial species and methods related thereto |
WO2021137494A1 (ko) * | 2020-01-02 | 2021-07-08 | 삼육대학교산학협력단 | 부티리시모나스 속 균주를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 조성물 |
WO2021142279A1 (en) * | 2020-01-10 | 2021-07-15 | Evelo Biosciences, Inc. | Compositions and methods of treatment using veillonella parvula |
WO2021146523A1 (en) * | 2020-01-17 | 2021-07-22 | Evelo Biosciences, Inc. | Solid dosage forms with improved disintegration profiles |
US20240009256A1 (en) * | 2020-02-04 | 2024-01-11 | University Of Louisville Research Foundation, Inc. | Use of probiotic bacterium-derived extracellular micro- and/or nanoparticles for the treatment of disease |
CN111052997B (zh) * | 2020-02-25 | 2022-07-01 | 青岛农业大学 | 一种提高草莓连作障碍抗性生物刺激素的制备及应用方法 |
US11744866B2 (en) | 2020-03-18 | 2023-09-05 | Sabine Hazan | Methods of preventing and treating COVID-19 infection with probiotics |
US11253534B2 (en) | 2020-03-23 | 2022-02-22 | Sabine Hazan | Method of preventing COVID-19 infection |
US11278520B2 (en) | 2020-03-31 | 2022-03-22 | Sabine Hazan | Method of preventing COVID-19 infection |
KR20220164002A (ko) * | 2020-04-03 | 2022-12-12 | 듀폰 뉴트리션 바이오사이언시즈 에이피에스 | 대사 건강 개선용 박테리아 균주를 포함하는 조성물 |
WO2021205444A1 (en) * | 2020-04-06 | 2021-10-14 | Yeda Research And Development Co. Ltd. | Methods of diagnosing cancer and predicting responsiveness to therapy |
KR102273234B1 (ko) * | 2020-05-08 | 2021-07-06 | 코스맥스 주식회사 | 코쿠리아 바리안스 균주 및 그의 피부 상태 개선 용도 |
KR102273232B1 (ko) * | 2020-05-08 | 2021-07-06 | 코스맥스 주식회사 | 마이크로코커스 리래 균주 및 그의 피부 상태 개선 용도 |
CN111560330B (zh) * | 2020-05-12 | 2022-04-26 | 天津科技大学 | 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用 |
GB202007452D0 (en) | 2020-05-19 | 2020-07-01 | Microbiotica Ltd | Threrapeutic bacterial composition |
WO2021242056A1 (ko) * | 2020-05-28 | 2021-12-02 | 주식회사 바이오뱅크힐링 | 비피도박테리움 속 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
TW202216178A (zh) * | 2020-06-11 | 2022-05-01 | 美商艾弗洛生物科技股份有限公司 | 使用巨型球菌屬物種治療疾病及障礙之組成物及方法 |
JP2023530888A (ja) * | 2020-06-11 | 2023-07-20 | エヴェロ バイオサイエンシズ,インコーポレーテッド | フルニエレラ・マシリエンシス(Fournierella massiliensis)を用いて疾患及び障害を治療するための組成物及び方法 |
US20230263838A1 (en) * | 2020-06-11 | 2023-08-24 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using oscillospiraceae microbial extracellular vesicles |
WO2021252860A2 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using harryflintia acetispora |
JP7385301B2 (ja) * | 2020-06-16 | 2023-11-22 | エムディー ヘルスケア インコーポレイテッド | ラクトバチルス・パラカゼイ由来小胞を含む神経疾患又は精神疾患の予防又は治療用組成物 |
EP4169520A1 (en) * | 2020-06-22 | 2023-04-26 | Rosetta Exosome Co., Ltd. | Method and composition for enhancing cancer treatment efficacy of bacteria extracellular vesicles |
KR102469138B1 (ko) * | 2020-07-07 | 2022-11-22 | 주식회사 엘제이바이오 | 파라클로스트리디움 벤조에리티쿰 ks3 균주를 포함하는 가축 사체 분해 촉진용 미생물 제제 |
CN111743922B (zh) * | 2020-07-14 | 2022-03-29 | 华熙生物科技股份有限公司 | 一种提高益生菌在鼻腔中的定植和活性的组合物及在鼻腔护理中的应用 |
CN116249540A (zh) * | 2020-07-21 | 2023-06-09 | 伊夫罗生物科学公司 | 小韦荣氏球菌菌株作为神经炎性疾病的口服疗法 |
US20230293599A1 (en) * | 2020-08-03 | 2023-09-21 | Universiteit Gent | Bacterial compositions with anti-inflammatory activity |
CN111876359A (zh) * | 2020-08-04 | 2020-11-03 | 榆林沙漠王生物科技有限公司 | 一种用于蔬菜残体资源化处理的复配菌剂及其制备方法及应用 |
US20230293600A1 (en) * | 2020-08-14 | 2023-09-21 | Kobiolabs, Inc. | Faecalibacterium prausnitzii strain and uses there of |
CN112094820B (zh) * | 2020-09-17 | 2021-12-07 | 扬州大学 | 霍氏肠杆菌噬菌体yzu.p.a-5及其应用 |
JP2023543416A (ja) * | 2020-09-18 | 2023-10-16 | エヴェロ バイオサイエンシズ,インコーポレーテッド | 細菌の固形剤形 |
CN112094328A (zh) * | 2020-09-21 | 2020-12-18 | 华南农业大学 | 一种空肠弯曲杆菌外膜囊泡的提取及纯化方法 |
TW202227111A (zh) * | 2020-09-21 | 2022-07-16 | 美商艾弗洛生物科技股份有限公司 | 具有改善的崩散譜之固體劑型 |
CN112094778B (zh) * | 2020-09-24 | 2022-06-24 | 千禾味业食品股份有限公司 | 一种魏斯氏菌las1、制备方法及其应用 |
US20240024377A1 (en) * | 2020-10-29 | 2024-01-25 | Evelo Biosciences, Inc. | Compositions comprising spirulina components |
CN114438235A (zh) * | 2020-11-04 | 2022-05-06 | 深圳市南山区疾病预防控制中心 | 一种同时检测嗜低温弓形杆菌及斯氏弓形杆菌的引物探针组件、试剂盒及其应用 |
WO2022124614A1 (ko) * | 2020-12-08 | 2022-06-16 | 주식회사 엠디헬스케어 | 스핀고모나스 세균 유래 소포를 포함하는 신경질환 또는 정신질환 예방 또는 치료용 조성물 |
KR102269962B1 (ko) | 2020-12-11 | 2021-06-28 | 주식회사 바이오뱅크힐링 | 유박테리움 리모숨 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
FR3118060A1 (fr) * | 2020-12-18 | 2022-06-24 | Université de Bourgogne | Utilisation anti-biofilm de vesicules membranaires extracellulaires |
WO2022139532A1 (ko) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | 와이셀라 헬레니카 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물 |
WO2022139530A1 (ko) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | 락토바실러스 사케아이 유래 세포밖 소포체를 유효성분으로 포함하는 자가면역질환의 개선, 예방 또는 치료용 조성물 |
WO2022139531A1 (ko) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | 류코노스톡 시트리움 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물 |
WO2022145902A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | 락토바실러스 사케아이 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
WO2022145901A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | 락토바실러스 퍼멘텀 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
WO2022145900A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | 와이셀라 시바리아 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
KR102651196B1 (ko) * | 2020-12-28 | 2024-03-27 | 주식회사 엠디헬스케어 | 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 안질환 예방 또는 치료용 조성물 |
WO2022145710A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 엠디헬스케어 | 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 신경발달 질환, 신경질환, 또는 정신질환 예방 또는 치료용 조성물 |
WO2022145680A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 엠디헬스케어 | 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 호중구성 폐질환의 예방 또는 치료용 조성물 |
WO2022154149A1 (ko) * | 2021-01-14 | 2022-07-21 | (주)엑솔런스 | 세포외소포체를 이용한 백신 조성물 |
JP2024505539A (ja) | 2021-02-01 | 2024-02-06 | エムディー ヘルスケア インコーポレイテッド | ラクトバチルス・パラカゼイ由来小胞を含むウイルス感染疾患または呼吸器疾患の予防、治療、または改善用組成物 |
WO2022177412A1 (ko) * | 2021-02-22 | 2022-08-25 | 주식회사 리스큐어바이오사이언시스 | 와이셀라 시바리아 균주 유래 나노소포체를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
WO2022182707A1 (en) * | 2021-02-26 | 2022-09-01 | Evelo Biosciences, Inc. | Compositions and methods for reducing cytokine expression |
AU2022232944A1 (en) * | 2021-03-12 | 2023-10-05 | MarvelBiome, Inc. | Methods and uses of microbiome compositions, components, or metabolites for treating eye disorders |
WO2022211547A1 (ko) * | 2021-04-02 | 2022-10-06 | 주식회사 엠디헬스케어 | 파라코커스 속 세균 유래 나노소포 및 이의 용도 |
CN113186172A (zh) * | 2021-04-06 | 2021-07-30 | 天津农学院 | 共表达Apoptin与MEL基因的重组腺病毒及构建方法和应用 |
WO2022221183A1 (en) * | 2021-04-12 | 2022-10-20 | Evelo Biosciences, Inc. | Fournierella extracellular vesicle preparations |
CN113025534B (zh) * | 2021-04-26 | 2022-05-27 | 佛山市南海东方澳龙制药有限公司 | 一株具有较强抑菌作用的新种芽孢杆菌x901株及其应用 |
CN115305211A (zh) * | 2021-05-07 | 2022-11-08 | 葡萄王生技股份有限公司 | 益生菌胞外泌体及其用途 |
CN113186134B (zh) * | 2021-05-17 | 2022-11-01 | 中国科学院水生生物研究所 | 一种蓝藻气囊提取方法及其应用 |
CN113122483A (zh) * | 2021-05-31 | 2021-07-16 | 哈尔滨工业大学 | 一种玉米秸秆好氧堆肥的快速产热菌剂及其应用 |
EP4349353A1 (en) * | 2021-06-03 | 2024-04-10 | MD Healthcare Inc. | Lactobacillus rhamnosus-derived vesicle and uses thereof |
EP4349354A1 (en) * | 2021-06-03 | 2024-04-10 | MD Healthcare Inc. | Extracellular vesicles derived from lactobacillus bacteria, and use thereof |
EP4119151A4 (en) * | 2021-06-03 | 2023-10-25 | MD Healthcare Inc. | COMPOSITION FOR THE PREVENTION OR TREATMENT OF EYE DISEASES COMPRISING EXTRACELLULAR VESICLES FROM LACTOBACILLUS PARACASEI |
KR102661178B1 (ko) * | 2021-06-03 | 2024-04-29 | 주식회사 엠디헬스케어 | 락토바실러스 파라카세이 유래 세포외소포를 포함하는 안질환 예방 또는 치료용 조성물 |
WO2022260352A1 (ko) * | 2021-06-07 | 2022-12-15 | 주식회사 엠디헬스케어 | 류코노스톡 세균 유래 소포를 포함하는 염증질환 또는 암 예방 또는 치료용 조성물 |
WO2023010074A1 (en) * | 2021-07-28 | 2023-02-02 | The Texas A&M University System | Vaccine compositions comprising brucella strains and methods thereof |
KR102390775B1 (ko) * | 2021-09-06 | 2022-05-04 | 한국식품연구원 | 류코노스톡 슈도메센테로이데스 WiKim0138 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
KR102390755B1 (ko) * | 2021-09-06 | 2022-04-28 | 한국식품연구원 | 웨이셀라 파라메센테로이데스 WiKim0137 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
KR102558084B1 (ko) * | 2021-09-14 | 2023-07-21 | 코스맥스 주식회사 | 두피 마이크로바이옴 콤플렉스 및 그의 모발 또는 두피 상태 개선 용도 |
CN113999789B (zh) * | 2021-09-30 | 2022-11-15 | 沈阳农业大学 | 一株产鲜味肽的嗜盐四联球菌及应用 |
WO2023062422A1 (en) * | 2021-10-11 | 2023-04-20 | Vastu Vihar Biotech Private Limited | An anti-inflammatory composition and a method of obtaining the same |
KR102411242B1 (ko) * | 2021-10-18 | 2022-06-22 | 큐티스바이오 주식회사 | 클렙시엘라 아에로제네스의 피부 상태 개선 용도 |
KR102411241B1 (ko) * | 2021-10-18 | 2022-06-22 | 큐티스바이오 주식회사 | 코리네박테리움 상귀니스의 피부 상태 개선 용도 |
KR20230056619A (ko) * | 2021-10-20 | 2023-04-27 | 주식회사 고바이오랩 | 항암 활성을 갖는 베일로넬라 파르불라 균주를 이용한 암의 완화, 예방 또는 치료용 조성물 |
WO2023075458A1 (ko) * | 2021-10-27 | 2023-05-04 | 주식회사 바이오뱅크힐링 | 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN114085792B (zh) * | 2021-11-17 | 2023-03-24 | 哈尔滨医科大学 | 一种用于防治结肠癌的副干酪乳杆菌及其应用 |
WO2023092141A2 (en) * | 2021-11-22 | 2023-05-25 | Dupont Nutrition Biosciences Aps | Compositions for metabolic health |
WO2023096858A1 (en) | 2021-11-23 | 2023-06-01 | Senda Biosciences, Inc. | A bacteria-derived lipid composition and use thereof |
WO2023114293A1 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Extracellular vesicle assays |
WO2023114300A1 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Fournierella massiliensis bacteria extracellular vesicle preparations |
CN114369673B (zh) * | 2022-01-06 | 2023-07-14 | 同济大学 | 结直肠腺瘤生物标志物、试剂盒及生物标志物的筛选方法 |
WO2023140603A1 (ko) * | 2022-01-20 | 2023-07-27 | 한국과학기술연구원 | 로세부리아 속 또는 비피도박테리움 속 유래 세포외소포체를 포함하는, 비알코올성 지방간 질환의 예방, 개선, 또는 치료용 조성물 |
CN114807032B (zh) * | 2022-05-20 | 2023-09-12 | 南京大学 | 地塞米松诱导中性粒细胞产生的细胞外囊泡在制备治疗消炎药物中的应用 |
KR102509869B1 (ko) * | 2022-07-14 | 2023-03-14 | 주식회사 엔테로바이옴 | 아커만시아를 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
KR102620189B1 (ko) * | 2022-08-31 | 2024-01-04 | 주식회사 바이오뱅크힐링 | 블라우티아 브룩킹시 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
KR102626400B1 (ko) * | 2022-08-31 | 2024-01-19 | 주식회사 바이오뱅크힐링 | 도레아 론기카테나 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
WO2024049207A1 (ko) * | 2022-08-31 | 2024-03-07 | 주식회사 바이오뱅크힐링 | 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
KR102620190B1 (ko) * | 2022-08-31 | 2024-01-04 | 주식회사 바이오뱅크힐링 | 아가토박터 렉탈리스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN116509900B (zh) * | 2022-12-01 | 2023-11-10 | 佛山科学技术学院 | 益生菌或其细胞外囊泡在制备防治胃溃疡产品中的应用 |
CN116622548B (zh) * | 2023-03-31 | 2024-02-09 | 吉林农业大学 | 一株能够预防和或治疗牙周炎的嵴链球菌及其应用 |
CN116747245A (zh) * | 2023-06-14 | 2023-09-15 | 内蒙古农业大学 | 动物双歧杆菌乳亚种bx-245在抑菌和/或生产功能活性物质中的应用 |
CN117180317B (zh) * | 2023-11-02 | 2024-01-26 | 深圳市第二人民医院(深圳市转化医学研究院) | 詹氏乳杆菌来源纳米囊泡在制备防治卵巢早衰治疗药物中的应用 |
CN117402794B (zh) * | 2023-12-12 | 2024-02-27 | 四川厌氧生物科技有限责任公司 | 一种加氏乳杆菌及其应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5322784A (en) | 1991-06-05 | 1994-06-21 | The Board Of Trustees Of The University Of Illinois, Urbana-Champaign, Illinois | Method and materials for introducing DNA into Prevotella ruminicola |
CA2400969C (en) | 2000-03-01 | 2011-04-19 | Societe Des Produits Nestle S.A. | Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine |
MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
GB0130123D0 (en) | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
CA2520830A1 (en) | 2003-03-31 | 2004-10-14 | Kirin Beer Kabushiki Kaisha | Method for inducing differentiation and/or proliferating regulatory t cells using anti-cd52 antibodies and pharmaceutical composition therefor |
EP2494865A4 (en) * | 2009-09-01 | 2014-05-14 | Aeon Medix Inc | EXTRACELLULAR VESICLES OBTAINED FROM THE DARMFLORA, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE AND CANDIDATE AND DIAGNOSTIC METHOD THEREFOR |
GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
US8617536B2 (en) | 2009-10-30 | 2013-12-31 | Mayo Foundation For Medical Education And Research | Prevotella histicola preparations and the treatment of autoimmune conditions |
KR101752506B1 (ko) | 2010-07-01 | 2017-06-30 | 포항공과대학교 산학협력단 | 세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법 |
WO2014152484A1 (en) * | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Freeze dried fecal microbiota for use in fecal microbial transplantation |
WO2012122478A1 (en) * | 2011-03-09 | 2012-09-13 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
TWI573590B (zh) | 2011-09-20 | 2017-03-11 | 雷希爾生藥有限公司 | 治療自體免疫疾病之組成物及方法 |
BR112014015940B1 (pt) | 2011-12-28 | 2022-08-09 | Galectin Therapeutics, Inc | Polissacarídeo de grau farmacêutico, composição, e seus usos |
SG11201510750XA (en) | 2013-06-03 | 2016-02-26 | Proprev Ab | Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella |
KR101740893B1 (ko) | 2014-05-20 | 2017-06-13 | 주식회사 엠디헬스케어 | Akkermansia muciniphila 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물 |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
JP2017537630A (ja) | 2014-12-03 | 2017-12-21 | カプリコール,インコーポレイテッド | 低酸素培養条件におけるエクソソームの生成方法 |
AU2016228888A1 (en) | 2015-03-12 | 2017-10-26 | The University Of British Columbia | Bacterial compositions and methods of use thereof |
US10722543B2 (en) | 2016-01-28 | 2020-07-28 | Oxyrase, Inc. | Methods for inhibiting tumor growth using anaerobe microorganisms |
MA50086A (fr) | 2017-09-08 | 2020-07-15 | Evelo Biosciences Inc | Vésicules extracellulaires (ev) bactériennes |
-
2018
- 2018-09-10 MA MA050086A patent/MA50086A/fr unknown
- 2018-09-10 AR ARP180102564A patent/AR113011A1/es unknown
- 2018-09-10 BR BR112020004264-1A patent/BR112020004264A2/pt unknown
- 2018-09-10 KR KR1020207010043A patent/KR20200053531A/ko not_active Application Discontinuation
- 2018-09-10 CA CA3075268A patent/CA3075268A1/en active Pending
- 2018-09-10 TW TW107131777A patent/TWI814739B/zh active
- 2018-09-10 US US16/645,019 patent/US11524037B2/en active Active
- 2018-09-10 AU AU2018330322A patent/AU2018330322A1/en not_active Abandoned
- 2018-09-10 EP EP18785472.4A patent/EP3678693A1/en active Pending
- 2018-09-10 JP JP2020513524A patent/JP7369690B2/ja active Active
- 2018-09-10 MX MX2020002659A patent/MX2020002659A/es unknown
- 2018-09-10 WO PCT/US2018/050211 patent/WO2019051380A1/en unknown
- 2018-09-10 CN CN201880058100.6A patent/CN111148531A/zh active Pending
-
2020
- 2020-04-06 CO CONC2020/0004233A patent/CO2020004233A2/es unknown
-
2022
- 2022-12-02 US US18/074,122 patent/US20230210913A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2019051380A1 (en) | 2019-03-14 |
AU2018330322A1 (en) | 2020-03-19 |
JP2020533290A (ja) | 2020-11-19 |
TW201919673A (zh) | 2019-06-01 |
CN111148531A (zh) | 2020-05-12 |
TWI814739B (zh) | 2023-09-11 |
CA3075268A1 (en) | 2019-03-14 |
US20200254028A1 (en) | 2020-08-13 |
JP7369690B2 (ja) | 2023-10-26 |
CO2020004233A2 (es) | 2020-04-24 |
US20230210913A1 (en) | 2023-07-06 |
BR112020004264A2 (pt) | 2020-10-06 |
US11524037B2 (en) | 2022-12-13 |
MX2020002659A (es) | 2020-09-09 |
EP3678693A1 (en) | 2020-07-15 |
KR20200053531A (ko) | 2020-05-18 |
MA50086A (fr) | 2020-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR113011A1 (es) | Vesículas extracelulares bacterianas | |
MX2018012553A (es) | Metodos para mejorar la produccion agricola de aves de corral mediante la administracion de consorcios microbianos o cepas purificadas de los mismos. | |
MX2018009539A (es) | Uso de comunidades microbianas para la salud humana y animal. | |
WO2019099682A9 (en) | Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strains | |
BR112017011923A2 (pt) | bactéria modificada para tratar doenças associadas com hiperamonemia | |
CL2021002602A1 (es) | Células microbianas, métodos para producir las mismas, y usos de las mismas (divisional de la solicitud no. 201902135) | |
CO2020003000A2 (es) | Tratamiento del virus del mosaico e infecciones bacterianas de plantas | |
MX2018012003A (es) | Composiciones producidas por microorganismos con actividad estimuladora sobre las plantas. | |
EA201890314A2 (ru) | Композиции, содержащие липохитоолигосахарид и микроорганизм для усиления роста растения | |
ECSP20084373A (es) | Tiofencarboxamidas sustituidas y análogos de las mismas | |
UY37562A (es) | Cepas bacterianas, composiciones que las comprenden, plantas y semillas tratadas con éstas y métodos relacionados | |
PH12017500708A1 (en) | Probiotic and prebiotic compositions | |
WO2019178487A3 (en) | Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae | |
AR113371A1 (es) | Aumento de la producción de aves de corral mediante la administración de un bioensamblaje sintético de microbios o cepas purificadas de los mismos | |
MX2021005518A (es) | Modelos animales, métodos de detección y métodos de tratamiento para enfermedades o trastornos intraoculares. | |
PH12017500059A1 (en) | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | |
PH12017500637A1 (en) | Inhibitors of lysine gingipain | |
CL2017001329A1 (es) | Conjunto bacteriano sinergístico destinado a movilizar el fósforo del suelo. | |
AR103531A1 (es) | Composiciones de caldo y su uso como prebióticos | |
PH12021551223A1 (en) | Decarboxylase inhibitors for treating parkinson`s disease | |
CL2017001818A1 (es) | Bacteria de ácido láctico y su uso para el tratamiento de mastitis | |
BR112021015638A2 (pt) | Métodos, composições contendo bactéria produtora de bacileno ou preparações das mesmas | |
AR112899A1 (es) | Vesículas extracelulares de prevotella en composición farmacéutica | |
AR127173A2 (es) | Composición agrícola para prevenir o controlar enfermedades de plantas | |
AR103086A1 (es) | Composiciones y métodos para reducir las infecciones en aves de corral |